PALISADE BIO, INC. — Director's Dealing 2022

May 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2022-04-29

Reporting Person: Finley John David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-29	Common Stock	J	12545	$0.00	Acquired	38867	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	21896	Direct

Footnotes

F1: Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution.

F2: The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity.